Product Information
VALPROIC ACID 250 MG CAPSULE is a generic product labeled by Actavis Pharma, Inc., priced at $0.2426 per EA under NDC 00591401201. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Oct 29, 1991. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591401201
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
VALPROIC ACIDApproval Type
Generic (ANDA)
FDA Application
ANDA073229FDA Approved
10/29/1991
TE Code
AB
On Market Since
9/8/2009
Pharmacological Classes
Price Statistics
The NADAC for VALPROIC ACID 250 MG CAPSULE has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 62.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2426 per EA |
|---|---|
| All-time high | $0.2584 (Mar 13, 2024) |
| All-time low | $0.1491 (Nov 28, 2013) |
| 52-week high | $0.2518 |
| 52-week low | $0.2337 |
| Median price | $0.2187 |
| Average price | $0.2087 |
| Largest weekly change | +31.7% (Jul 19, 2017) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Actavis Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Valproic Acid market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-epileptic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VALPROIC ACID 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for VALPROIC ACID 250 MG CAPSULE, manufactured by Actavis Pharma, Inc., is $0.2426 per EA (NDC 00591401201), effective Sep 30, 2026.
How has the price of VALPROIC ACID 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for VALPROIC ACID 250 MG CAPSULE has risen 62.7%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VALPROIC ACID 250 MG CAPSULE?
Since Nov 28, 2013, the NADAC for VALPROIC ACID 250 MG CAPSULE has ranged from a low of $0.1491 (Nov 28, 2013) to a high of $0.2584 (Mar 13, 2024), with a median of $0.2187 per EA.
Are there cheaper alternatives to VALPROIC ACID 250 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as VALPROIC ACID 250 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures VALPROIC ACID 250 MG CAPSULE?
VALPROIC ACID 250 MG CAPSULE (NDC 00591401201) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.